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METHODS
Participants
EPIC investigates the role of biological, dietary and lifestyle factors in the aetiology of cancer and other chronic diseases. More than 521,000 apparently healthy men and women, aged 25 to 70 years, were recruited between 1992 and 2000 in 23 centres from 10 European countries (Denmark, France, Germany, Greece, Italy, the Netherlands, Norway, Spain, Sweden, and United Kingdom (UK)). The participants were selected from the general population, except for France (women-members of health insurance plans), Utrecht and Florence (women -breast cancer screening), Naples and Norway (women only), the Oxford cohort (which includes a large proportion of vegetarian volunteers) and subsamples of the Italian and Spanish cohorts (mainly members of blood donor associations). Details of EPIC are given elsewhere. 10 The study was approved by the Ethical Review Board of the International Agency for
Research on Cancer, and by the local Ethics Committees in the participating centres.
Participants gave informed consent before enrolment. Procedures were in line with the Helsinki declaration.
Assessment of diet
Dietary intakes over the previous year were assessed at enrolment through validated centre-specific questionnaires which enquired also about cups of coffee and tea 11 consumption per day, week or month. 11 In some centres, additional information on caffeinated and decaffeinated coffee consumption was obtained (Germany, Greece, Italy (except Ragusa and Naples), Netherlands, and UK). Information on tea consumption was not available in Norway. Data on type of tea were not available.
Based on the information collected by the questionnaires, beverage intakes were calculated in each center in ml/day in order to take into account differences in cup sizes by region. Total energy intake was calculated through the EPIC Nutrient-DataBase. 
13
Statistical analysis
The associations of coffee, caffeinated/decaffeinated coffee, and tea intake with HCC risk were investigated through Cox proportional hazard models. Age at exit was the underlying time variable defined as the age of: HCC diagnosis (case); diagnosis of any other incident cancer (censored); death for participants who died without cancer (censored); last follow-up for those alive and with no cancer (censored). Age at recruitment was the entry time. All models were stratified by recruitment age (1-year intervals) and study centre.
Coffee intake was considered in sex-specific quintiles (Q1-Q5). For tea, due to the large number of non-consumers (153,097/450,921, 34%), five categories of intake (C1-C5) were created: non-consumers (C1) and the sex-specific quartiles (C2-C5) among consumers. Both variables were considered categorically and per one-level increments. Norway was excluded from tea analyses, as no relevant data were available. Due to potential between-countries variations in coffee/tea volume and concentration, we also based estimation of quintiles of coffee and categories of tea on sex-and-country specific intakes in order to check the robustness of our findings.
Linear trends were evaluated using the medians of quintiles/categories as continuous variables in the Cox models. In additional models, coffee and tea were mutually adjusted for.
14 In analyses by type of coffee, only data from 163,672 participants (Germany, Netherlands and United Kingdom), for whom the sum of caffeinated and decaffeinated coffee equals the total amount of coffee intake, were included. Due to the large number of non-consumers of decaffeinated coffee (35%) we considered 3 categories for this beverage: (i) C1: non-consumers, (ii) C2: consumers below the median (among consumers), and (iii) C3: consumers at/above the median (among consumers). To preserve comparability here, caffeinated coffee and tea were also analysed in 3 categories defined as for decaffeinated coffee.
In all analyses, potential confounders were: sex, self-reported diabetes (categorically:
no, yes, unknown), education (categorically: no formal/primary school, technical/secondary school, university /longer, unknown), physical activity (categorically: inactive/moderately inactive, moderately active/active, unknown), smoking (categorically: never, former smoker, current smoker, unknown), ethanol intake (categorically: low: men< 10g/day, women <5 g/day; moderate: men 10-<40 g/day, women 5-<20 g/day; high: men >40 g/day, women >20 g/day), body mass index (categorically: <25 kg/m 2 , >25 to <30 kg/m 2 , >30 kg/m 2 ) and energy intake (ordered, in sex-specific quintiles). In order to minimize residual confounding by smoking/ethanol intake, we further used more detailed variables (but with more missing values), accounting for intensity and/or duration of smoking and lifetime alcohol drinking. Deviations from log linearity of the associations between coffee/tea intakes and HCC risk were assessed by: a) comparing models including coffee/tea intakes as ordered, with models including both dietary exposures as categorical, using the Likelihood Ratio test (LRtest), b) by applying restricted cubic splines Cox regression models for coffee/tea intakes and testing (using the Wald test and the
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LRtest) whether these models were of better fit as compared to models which assumed simpler, log linear associations between coffee/tea and HCC risk, and c) by inspecting the Akaike's Information Criterion (AIC) in models assuming restricted cubic splines for the indicated associations as compared to models of linear trends which are shown in Table 3 .
We performed several sensitivity analyses (see Results). Furthermore, we investigated whether the estimated associations differed across strata defined by sex (men/women), diabetes (yes/no), smoking (never/former/current), ethanol intake (low/moderate/high as indicated above) and body mass index (<25 kg/m 2 / >25 to <30 kg/m 2 / >30 kg/m 2 ), by introducing interaction terms between quintiles/categories of coffee/tea intake (ordered) and each of the indicated variables (categorically). In order to evaluate whether the associations between coffee/tea intake and HCC risk varied by positivity status regarding hepatitis B virus (HBV) and/or hepatitis C virus (HCV), we used data from the nested case-control study 13 and introduced interaction terms in conditional logistic regression models between HBV/HCV status (yes/no) and coffee/tea intakes; in this analysis, coffee/tea intakes were considered in tertiles (T1-T3, using control-defined cut-off values) due to the small number of controls.
P<0.05 was considered statistically significant. All analyses were performed using STATA (Stata Corporation: Stata statistical software, release 11. College Station. TX: Stata Corporation; 2009).
RESULTS
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After a median follow-up of 11 years, 1,622,408 and 3,744,060 person-years were accrued from the 145,039 (30%) men and 341,760 (70%) women of the study population, respectively, and 133 men and 68 women were diagnosed with HCC. Danes consuming the highest quantities. Participants with higher coffee intakes were slightly older, more educated, reported less frequently diagnosis with diabetes, were more frequently smokers, consumed higher amounts of ethanol, had lower body mass index, were more active and had higher energy intake.
In Table 2 , corresponding distributions as in Table 1 are presented by categories of tea intake. Among tea consumers (66% of the total cohort), median intakes were 107 ml/d for men and 190 ml/d for women. Distribution of participants across categories of tea intake varied across countries, with the highest intakes consumed in the UK.
Consumers of high tea intakes were more educated, more active, former smokers, moderate ethanol drinkers, reported less frequently diabetes, and had lower body mass index. Table 3 shows hazard ratios (HRs) for HCC incidence by quintiles/categories of coffee/tea intakes, separately (models 1 and 2) and after mutual adjustment (model 3).
Increased coffee intake was associated with a substantial, monotonic and statistically significant reduction in HCC risk, in all models. This inverse association was more pronounced when coffee and tea were considered simultaneously (HR Q5vsQ1 , 0.28; 95% confidence interval (CI), 0.16 to 0.50). Tea intake was also inversely associated with HCC incidence, with a linear trend apparent in all models (particularly model 3).
There was no statistical evidence indicating that models assuming a log linear association between coffee/tea intakes and HCC risk were of inferior fit as compared to models with no assumption for the type of association of coffee/tea with HCC risk (i.e., using coffee/tea intakes in quintiles/categories, categorically): LRtest coffee =0.707, LRtest tea =0.683. Similarly, there was no evidence that restricted cubic splines regression models were of better fit as compared to simpler models assuming log linear associations between coffee/tea and HCC risk (p-value from Wald test:
coffee: 0.13; tea: 0.78). The AIC for model 3 of Table 3 of linear trends (AIC=2372.795) indicated a slightly better model fit as compared to the restricted cubic splines models for coffee (AIC=2379.004) and tea (AIC= 2409.564).
More detailed control for smoking (i.e., smoking intensity/duration) and alcohol intake (e.g. lifetime alcohol consumption), as well as, the inclusion of body mass index and energy intake as continuous rather than as categorical variables, generated very similar results.
Sensitivity analyses
Sensitivity analyses focussed on model 3 (Table 3) . When subjects without missing values were studied (187 HCC cases/413,666 participants), HRs and 95% CIs were essentially identical to those reported in Table 3 . When 9,596 subjects (10 HCC cases) in the top/bottom 1% of the energy intake distribution were excluded, results
were also similar to those previously reported (coffee: HR Q5vsQ1 , 0.26; 95% CI, 0.14 to 0.48 (P-trend <0.001); tea: HR C5vsC1 , 0.36; 95% CI, 0.18 to 0.73 (P-trend=0.002)).
When analyses were restricted to the 167 histologically confirmed HCC cases with tea consumption information, the inverse associations of coffee/tea with HCC risk followed the same linear trends (coffee: P-trend <0.001; tea P-trend=0.009). longer statistically significant, possibly on account of scarcity of data (P-trend=0.08).
Examination of effect-modifications
Interactions were evaluated among participants without missing data and were, generally, far from statistically significant. The associations of both beverages were considerably weaker among diabetics, but the interaction terms were statistically nonsignificant (coffee, P-interaction=0.14; tea, P-interaction =0.20 
DISCUSSION
In a multi-centre European cohort, we found evidence that intakes of coffee and, to a lesser extent, tea are associated with lower HCC incidence. Both associations followed statistically significant linear trends, which were also generally apparent in 20 subgroup analyses. Compared to those with minimal or no consumption of coffee, and adjusted also for tea intake, those in the highest quintile of coffee intake had a statistically significantly lower HCC risk by about 70%. For tea, the corresponding contrast was milder than that for coffee, with the risk in the highest quintile being about 60% lower in comparison to the lowest quintile (composed exclusively by nonconsumers). This is the first multi-centre cohort study in a western population which has investigated simultaneously and with mutual adjustment the association of coffee and tea intakes with HCC risk.
Our results are in line with those reported in previous case-control [14] [15] [16] and cohort [17] [18] [19] [20] [21] [22] Asian studies, as well as in three case-control studies [23] [24] [25] and in two, moderatelysized, cohort studies conducted in Europe 5, 6 with respect to: a) the inverse association of coffee consumption with HCC risk, b) the linear trend in risk reduction with increasing coffee intake, and c) the consistency of these findings across various subgroups. In a recent meta-analysis, 8 including all indicated studies, as well as three studies reporting statistically non-significant inverse 19, 26 [30] [31] [32] [33] two null associations, 19 ,34 whereas three reported positive, albeit statistically nonsignificant associations. 17, 25, 35 A meta-analysis of these studies 9 pointed to a suggestive inverse association of tea with primary liver cancer. Our study, the first 21 cohort study outside Asia, indicates an inverse, dose-dependent association of tea with HCC risk, which is not incompatible with the results of the indicated meta-analysis, although our findings point to a stronger inverse association.
Several mechanisms could underlie the inverse association between coffee intake and HCC. Coffee has been inversely related to chronic liver disease, 36,37 cirrhosis, 37, 38 or diabetes mellitus. 39 In previous studies, however, the inverse association between coffee and HCC risk was evident in subjects irrespectively of chronic liver disease, or HBV/HCV status. 8 When we excluded the first 2 years of follow-up, which would exclude a fraction of cases with underlying liver disease, results were largely unchanged. Moreover, adjusting for chronic HBV/HCV infection in our nested casecontrol study, did not materially affect the results, nor was there a statistically significant interaction between virus carrier state and coffee (and tea) intake with respect to HCC risk -a finding with considerable clinical importance, 40 given the high HCC risk of HBV/HCV carriers. Of note, our results were adjusted for diabetes and there was no evidence for diabetes-by-coffee (or tea) interaction.
Coffee contains several hundred chemical compounds including caffeine, diterpenes, chlorogenic acids and flavonoids, with reported anti-hepatocarginogenic effects. 41 Regarding caffeine intake, in a subset of our data, intake of caffeinated coffee, tea and decaffeinated coffee appear to be inversely related to HCC risk but the association is strong and statistically significant for caffeinated coffee, weaker and statistically nonsignificant for tea and still weaker for decaffeinated coffee. Taking into account, the correspondence with the caffeine content of the three beverages and given that caffeine content (not content of other antioxidant compounds) 42 is the defining 22 difference between caffeinated and decaffeinated coffee, a key role of caffeine cannot be excluded. We did not have available information on the amount of caffeine intake (from all food/beverage sources) in order to better explore the potential role of caffeine on the inverse association of coffee with HCC risk. The possible differential association of caffeinated and decaffeinated coffee with HCC risk needs to be further explored, preferably in other large cohort studies.
Regarding tea, experimental studies have suggested a hepatoprotective effect, mainly invoking antioxidative properties of green tea polyphenols. 43 There was no adequate information on type of tea in our cohort, but Europeans are likely to consume mostly black rather than green tea. Given the inconclusive collective evidence in the literature, further studies are needed to affirm any protective role of tea on HCC risk before exploring the underlying mechanisms.
Strengths of our study are its cohort design, its multi-centre coverage allowing to examine a variable range of tea and coffee intakes across European countries, the use of validated questionnaires, the relatively long follow-up, the common identification In conclusion, in a large prospective study across European countries, we found evidence that increased coffee and tea intakes are associated, in a dose-dependent pattern, with lower HCC risk. The estimated risk reduction was stronger for coffee than for tea, whereas there was no convincing evidence for an association of decaffeinated coffee with HCC. Given the apparent lack of heterogeneity of the HCC associations with coffee and tea by HBV/HCV positivity status or other risk factors, the results may even have important implications for high HCC risk subjects.
Mechanistic studies could clarify whether the noted associations could be attributed to caffeine, or, to other constituents of these beverages. 
